PR Newswire
PR Newswire is the industry’s leading press release distribution partner with an unparalleled global reach of more than 440,000 newsrooms, websites, direct feeds, journalists and influencers and is available in more than 170 countries and 40 languages. From our award-winning Content Services offerings, integrated media newsroom and microsite products, Investor Relations suite of services, paid placement and social sharing tools, PR Newswire has a comprehensive catalog of solutions to solve the modern-day challenges PR and communications teams face. For 70 years, PR Newswire has been the preferred destination for brands to share their most important news stories across the world.
SUEZ commissions China’s largest industrial membrane-based seawater desalination plant for Wanhua Chemical’s Penglai Industrial Park to support industrial needs while conserving scarce water resources
YANTAI, China, April 28, 2025 /PRNewswire/ -- A landmark seawater desalination plant, designed and built by SUEZ for Wanhua Chemical Group—one...
Read more
The 6th “Design Licensing and Business (DLAB) Support Scheme” Launching Ceremony of DLAB Hong Kong Pavilion in HK Int’l Licensing Show 2025
43 Participating Local Design Companies Make a Remarkable Debut, Witnessing a New Milestone in the Hong Kong's Creative Industries HONG...
Read more
BGM Completes Acquisition of YX to Advance AI-Powered Intelligent Platform
CHENGDU, China, April 28, 2025 /PRNewswire/ -- BGM Group Ltd. (NASDAQ: BGM) (the "Company" or BGM) today announced the completion...
Read more
Yiren Digital Files 2024 Annual Report on Form 20-F
BEIJING, April 28, 2025 /PRNewswire/ -- Yiren Digital Ltd. (NYSE: YRD) ("Yiren Digital" or the "Company"), an AI-powered platform providing...
Read more
Marvion Inc. Announces Annual Financial Results for 2024 with 134% Gain in Year-to-Year Revenue
HONG KONG, April 28, 2025 /PRNewswire/ -- Marvion Inc. (OTC: MNVC) filed and reported the financial results with the period ended...
Read more
Kangpu Biopharmaceuticals Received CDE Approval for Phase IIb Clinical Trial of KPG-818 in Moderate to Severe Cutaneous Manifestations of SLE
HEFEI, China, April 28, 2025 /PRNewswire/ -- Kangpu Biopharmaceuticals, Ltd. announced today that the Center for Drug Evaluation (CDE) of...
Read more
Sky Labs’ CART BP pro at the Heart of New Research on Sleep Apnea and Nocturnal Hypertension
SEOUL, South Korea, April 28, 2025 /PRNewswire/ -- Sky Labs, a health-tech startup based in South Korea and the developer of CART BP...
Read more
Celltrion to present six abstracts in inflammatory bowel disease (IBD) at 2025 Digestive Disease Week® (DDW)
Six abstracts accepted for presentation includes post hoc analyses and real-world evidence for ZYMFENTRA® (infliximab-dyyb) Findings reinforce clinical decision-making in long-term...
Read more
Appknox Launches Storeknox, Revolutionizes Mobile App Security with Continuous Store Monitoring
New solution empowers enterprises to protect against post-launch app threats, fake apps and brand abuse SINGAPORE, April 28, 2025 /PRNewswire/...
Read more
WOORI FINANCIAL GROUP INC. FILES ITS ANNUAL REPORT ON FORM 20-F
SEOUL, South Korea, April 28, 2025 /PRNewswire/ -- On April 28, 2025, Woori Financial Group Inc. (NYSE:WF) (KRX:316140) filed its...
Read more
Stay ahead with the latest insights on Hong Kong’s economy, finance, and investments. From market trends to policy updates, we bring you in-depth analysis and expert opinions.
📩 Subscribe to our newsletter for exclusive updates.
📍 Follow us on social media for real-time news.
📧 Contact us: [email protected]